الأربعاء, 23 أيار 2012   3. رجب 1433

 

 

 

 

 

 

 

 

صورة واجمل تعليق

vtem news box

  متى سيتم صرف الادوية بهذه الطريقة ؟؟؟ وهل تعتقدون ان هذه الطريقة ستنجح لدينا في الدول العربية ؟؟؟ ثم ما هو مصير الصيدلاني ؟؟؟…

 

 

 

مقالات طبية وصحية

القائمة البريدية

 

 GlaxoSmithKline and Valeant Pharmaceuticals announced that the European Medicines Agency's Committee for Medicinal Products for

Human Use issued a positive opinion recommending marketing approval of Trobalt (retigabine) as an adjunctive treatment for partial onset seizures in adults with epilepsy.


The drug, which is known as ezogabine in the US, is being jointly developed by the two companies. In December, Trobalt received a preliminary approval from Swissmedic.